Announcements Trials

Browse Landscape

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Rectal Neoplasms 5 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Kidney Neoplasms 2 Colorectal Neoplasms 2 Uterine Neoplasms 1 Thyroid Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Anastomotic Leak 1

Interventions

Exercise 19 Drug Therapy 18 pembrolizumab 13 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Paclitaxel 9 Dexamethasone 9 Nivolumab 8 Standard of Care 7 Oxaliplatin 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Control Groups 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Robotic Surgical Procedures × Clear all

NCT04647188 2023-09-26

MASTERY

University of Birmingham

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡